Activation of human somatostatin receptor type 2 causes inhibition of cell growth in transfected HEK293 but not in transfected CHO cells

Journal of Surgical Research

Volumn 71, Issue 1, 1997, Pages 13-18

  Ren, J ^a   Bell, G ^b   Coy, D H ^c   Brunicardi, F C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC G 418; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; VAPREOTIDE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHO CELL; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031571102     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5097     Document Type: Article

References (49)

1. Reichlin S. Somatostatin. N. Engl. J. Med. 309:1983;1495.
2. Reisine T., Bell G. I. Molecular properties of somatostatin receptors. Neuroscience. 67:1995;777.
3. Patel Y. C., Greenwood M. T., Panetta R., Demchyshyn L., Niznik H., Srikant C. B. Mini review the somatostatin receptor. Fam. Life Sci. 57:1995;1249.
4. Bloom S., Mortimer C., Thorner M., Besser G., Hall R. Inhibition of gastrin and gastric acid secretion by growth hormone release-inhibitory hormone. Lancet. 2:1974;1106.
5. Tannenbaum G., Ling N., Brazeau P. SRIF 28 is longer acting and more selective than SRIF on pituitary and pancreatic hormone release. Endocrinology. 111:1982;101.
6. Gomez-pan A., Reed J., Albinus M., Shaw B. Direct of gastric acid and pepsin secretion by growth-hormone release-inhibiting hormone in rat. Lancet. 1:1975;888.
7. Epelbaum J. Somatostatin in the central nervous system: Physiology and pathological modification. Prog. Neurobiol. 27:1986;63.
8. Brazeau P., Vale W., Burgus R., Ling N., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 129:1973;77.
9. Pradayrol L., Jornvall H., Mutt V. N-terminally extended somatostatin: The primary structure of somatostatin-28. FEBS Lett. 109:1980;55.
10. Schally A. V. Oncological application of somatostatin analogues. Cancer Res. 48:1988;6977.
11. Vanetti M., Kouba M., Wang X., Vogt G., Hoellt V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett. 311:1992;290.
12. Patel Y. C., Greenwood M., Kent B., Panetta R., Srikant C. B. Multiple gene transcripts of the somatostatin receptor SSTR2: Tissue selective distribution and cAMP regulation. Biochem. Biophys. Res. Commun. 192:1993;288.
13. Taylor J. E., Theveniau M. A., Bashirzadeh R., Resine T., Eden P. A. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: Evidence for SSTR2 heterogeneity. Peptides. 15:1994;1229.
14. Yamada Y., Post S. R., Wang K. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. USA. 89:1992;251.
15. Yamada Y., Reisine T., Law S. F. Somatostatin receptors, an expanding Gene family: Cloning and human SSTR3, a protein coupled to adenylyl cyclase. Mol. Endocrinol. 6:1992;2136.
16. Yamada Y., Kagimoto S., Kubota A. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem. Biophys. Res. Commun. 195:1993;844.
17. Rohrer L., Raulf F., Bruns C. Cloning and characterization of a fourth human somatostatin receptor. Proc. Natl. Acad. Sci. 90:1993;4196.
18. Panetta R., Greenwood M. T., Warszynska A. Molecular cloning, functional characterization and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity with somatostatin-28. Mol. Pharmacol. 45:1994;417.
19. Breder C. D., Yamada Y., Yasuda K., Seino S., Saper C., Bell G. I. Differential expression of SRIF receptor subtypes in brain. J. Neurosci. 12:1992;3920.
20. Bruno J. F., Xu Y., Song J., Berelowitz M. Tissue distribution of SRIF receptor subtype messenger ribonucleic acid in the rat. Endocrinology. 133:1993;2561.
21. Kong H., DePaoli A. M., Breder C. D., Yasuda K., Bell G. I., Reisine T. Differential expression of SRIF receptor subtypes SSTR1, SSTR2 and SSTR3 in adult rat brain, pituitary and adrenal gland. Analysis by RNA blotting and in situ hybridization. Neuroscience. 59:1994;175.
22. Raulf F., Perez J., Hoyer D., Bruns C. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion. 55:1994;46.
23. Kluxen F. W., Bruns C., Luebbert H. Expression and cloning of a rat brain somatostatin receptor cDNA. Proc. Natl. Acad. Sci. 89:1992;4618.
24. O'Carroll A. M., Lolait S. J., Konig M., McMahan L. C. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol. Pharmacol. 42:1992;939.
25. Patel Y. C., Srikant C. B. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hSSTR1-5). Endocinology. 135:1994;2814.
26. Moldovan S., Atiya A., Adrian T. E., Kleinman R. M. Somatostatin inhibits B-cell secretion via a subtype-2 somatostatin receptor in the isolated perfused human pancreas. J. Surg. Res. 59:1995;85.
27. Kaupmann K., Bruns C., Hoyer D., Seuwen K., Luebbert H. Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. FEBS Lett. 331:1993;53.
28. Strnad J., Eppler C. M., Corbett M., Hadcork J. R. The rat SSTR2 somatostatin rceptor subtype is coupled to inhibition of cyclic AMP accumulation. Biochem. Biophys. Res. Commun. 191:1993;968.
29. Yasuda K., Rens-Domiano S., Breder C. D. Cloning of a novel somatostatin receptor, sstr3, coupled to adenylyl cyclase. J. Biol. Chem. 267:1992;20422.
30. Raynor K., O'Carroll A. M., Kong H. Y. Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol. Pharmacol. 44:1993;385.
31. Patel Y. C., Greenwood M. T., Warszynska A., Panetta R., Srikant C. B. All five cloned human somatostatin rceptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem. Biophys. Res. Commun. 198:1994;605.
32. 2+. Biochem. Biophys. Res. Commun. 200:1994;986.
33. 2+. FEBS Lett. 348:1994;192.
34. 2+. Biochem. Biophys. Res. Commun. 214:1995;81.
35. Liebow C., Reilly C., Serrano M., Schally A. V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. USA. 86:1989;2003.
36. Setyono-Han B., Henkelman M. S., Foekens J. A., Klijn J. G. M. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cell lines. Cancer Res. 47:1987;1566.
37. Scambia G., Panici P. B., Baiocchi G., Perrone L., Oacobelli S., Mancuso S. Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines. J. Cancer Res. Clin. Oncol. 114:1988;306.
38. Qin Y., Schally A. V., Willems G. Somatostatin analogues RC-160 inhibits the growth of transplanted colon cancer in rats. Int. J. Cancer. 47:1991;765.
39. Tsuzaki S., Moses A. C. Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-1 in FRTL5 cells. Endocrinology. 126:1990;3131.
40. Schally A. V., Redding R. W. Somatostatin analogs as adjuncts to agonist of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer. Proc. Natl. Acad. Sci. USA. 84:1987;7275.
41. Taylor J. E., Moreau J. P., Baptiste L., Moody T. W. Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells. Peptides. 12:1990;839.
42. Lamberts S. W. J., Krenning E. P., Reubi J. C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrinol. Rev. 12:1991;450.
43. Lee M. T., Liebow C., Kamer A. R., Schally A. V. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc. Natl. Acad. Sci. USA. 88:1991;1656.
44. Buscail L., Delesque N., Esteve J. P., Saint-Laurent N. Stimulation of tyosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc. Natl. Acad. Sci. USA. 91:1994;2315.
45. Rens-Domiano S., Law S. F., Yamada Y., Seino S., Bel G. I., Reisine T. Pharmacological properties of two cloned SRIF receptors. Mol. Pharmacol. 42:1992;28.
46. Raynor K., Murphy W. A., Coy D. H. Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol. Pharmacol. 43:1993;838.
47. Rossowski W. J., Coy D. H. Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs. Biochem. Biophys. Res. Commun. 205:1994;341.
48. Buscail L., Esteve J. P., Saint-Laurent N., Bertrand V., Reisine T., O'Carroll A. M., Bell G. I., Schally A., Vaysse N., Susini C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by SSTR2 and SSTR5 somatostatin receptor subtypes through different mechanisms. Proc. Natl. Acad. Sci. USA. 92:1995;1580.
49. Florio T., Rim C., Hershberger R. E., Loda M., Stork P. J. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol. Endocrinol. 8:1994;1289.